Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 232 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3280 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALLOPURINOL TABLETS 100MG TABLET Resolved 2024-08-01 2024-10-07 234330
APO-ALLOPURINOL TABLETS 100MG TABLET Resolved 2024-08-01 2024-10-07 234333
APO-ALLOPURINOL TABLETS 200MG TABLET Resolved 2024-08-01 2024-10-07 234338
APO-ALLOPURINOL TABLETS 200MG TABLET Resolved 2024-08-01 2024-10-07 234342
APO-ALLOPURINOL TABLETS 300MG TABLET Resolved 2024-08-01 2024-10-07 234345
APO-ALLOPURINOL TABLETS 300MG TABLET Resolved 2024-08-01 2024-10-07 234351

Showing 3521 to 3526 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MELPHALAN FOR INJECTION 10ML 50MG POWDER FOR SOLUTION KIT SOLUTION Discontinued 2022-03-23 2022-03-23 157136
NAPROXEN SODIUM TABLETS 220MG TABLET Discontinued 2019-01-04 2019-01-04 71228
APO-PENTOXIFYLLINE SR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-23 2022-01-27 65438
APO-TEMAZEPAM 15MG CAPSULE Discontinued 2018-10-23 2019-01-14 65477
APO-TEMAZEPAM 30MG CAPSULE Discontinued 2018-10-23 2019-01-07 65482
TIGECYCLINE 50MG POWDER FOR SOLUTION To be discontinued 2019-06-21 2019-06-21 87218

Showing 361 to 366 of 366